Delivery Order SPE2DB22D2206-SPE2DB26FDS26
- Not listed
- The Defense Logistics Agency awarded a $1,045.00 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Quillichew ER 30 mg chewable tablets (100-count package). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 9, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Quillichew ER 30 mg chew tablets (100-count packages) valued at $2,831.31. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The order is to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Quillichew ER 30 mg chew tablets in quantities of 100 units. This is a firm fixed-price delivery order with a ceiling value of $1,752.85 and an ultimate completion date of August 7, 2025. The contract was awarded on a competitive basis with no set-aside designation, and performance will be executed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Quillichew ER 40 mg chew tablets (100-count units) with a firm fixed price ceiling value of $2,420.40. This is a non-set-aside, competitively awarded contract with an ultimate completion date of October 17, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,045.00 to AmerisourceBergen Drug Corp for the supply of Quillichew ER 30 mg chew tablets (100 count) on May 13, 2025, with an ultimate completion date of May 14, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a discrete transaction under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Quillichew ER 20 mg chew tablets (100-count units) valued at $3,095.96. This competitively awarded, firm fixed-price contract was issued on August 5, 2025, with an ultimate completion date of August 6, 2025. The pharmaceutical product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $1,047.54 to AmerisourceBergen Drug Corp for Quillichew ER 40 mg chewable tablets (100-count units) on June 6, 2025, with an ultimate completion date of June 9, 2025. This firm fixed-price delivery order represents a non-competitive set-aside procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The product will be sourced from the vendor's Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 14, 2025, for the supply of Quillichew ER 30 mg chew tablets (100-count units) with a contract value of $8,334.51. This is a firm fixed-price delivery order with an ultimate completion date of October 15, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued as a...
- The Defense Logistics Agency awarded a $1,271.33 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Quillichew ER 30 mg chew tablets (100-count units). This non-set-aside competitive award will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Quillichew ER 40 mg chew tablets (100 count) with a ceiling value of $2,039.64. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive procurement practices. The order is scheduled for completion by August 7, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB26FDS26Delivery Order
The Defense Logistics Agency awarded a $1,047.54 delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Quillichew ER 40 mg chewable tablets (100-count units). This firm fixed price, competitively awarded contract utilizes no set-aside designation and is scheduled for completion by October 21, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution operations. This delivery order represents a child contract issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen supplies pharmaceutical products and medical commodities to support military and veteran healthcare systems. The Quillichew procurement supports federal medical supply requirements, with the company's extensive contract portfolio demonstrating its capability to deliver diverse pharmaceutical products across multiple therapeutic domains through competitively awarded delivery orders with the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 10/20/25 |